Dr. Frank, The DSMC recommendation was very pos
Post# of 155675
(Total Views: 532)
Posted On: 10/21/2020 10:04:42 AM
Dr. Frank,
The DSMC recommendation was very positive. You may be a trader or an anxious investor, but most here I believe are investors with confidence and a long-term vision who recognize the opportunity of Cytodyn.
I am not a trader and know I cannot possibly compete with Wall Street and computer driven trading. There is nothing most of us can do with our money over 2-3 months that will make a difference. I have invested as the science of Leronlimab is something I can understand and in which I have invested confidently.
Like many of the new investors, I am completely underwater in Cytodyn. I'm ok with that. It is not Wallstreet or Cytodyn's fault that I did not recognize this opportunity year ago like Ohm, Tech, OMandarin, SAF, Goosebumps, CDiddy, etc.
Uplist is dead for now. It does not matter for now. It is not a protection against shorting (look at overstock from three years ago. shorted mercilessly, not up 9x this year).
Management continues to move this company forward while the competitors fall by the wayside.
If you don't have the stomach to wait 3 months, there are many other investment opportunities. I'm a newbie, but I'm staying here with the longs. Cytodyn will prevail regardless of your or my investment or advocacy.
The DSMC recommendation was very positive. You may be a trader or an anxious investor, but most here I believe are investors with confidence and a long-term vision who recognize the opportunity of Cytodyn.
I am not a trader and know I cannot possibly compete with Wall Street and computer driven trading. There is nothing most of us can do with our money over 2-3 months that will make a difference. I have invested as the science of Leronlimab is something I can understand and in which I have invested confidently.
Like many of the new investors, I am completely underwater in Cytodyn. I'm ok with that. It is not Wallstreet or Cytodyn's fault that I did not recognize this opportunity year ago like Ohm, Tech, OMandarin, SAF, Goosebumps, CDiddy, etc.
Uplist is dead for now. It does not matter for now. It is not a protection against shorting (look at overstock from three years ago. shorted mercilessly, not up 9x this year).
Management continues to move this company forward while the competitors fall by the wayside.
If you don't have the stomach to wait 3 months, there are many other investment opportunities. I'm a newbie, but I'm staying here with the longs. Cytodyn will prevail regardless of your or my investment or advocacy.
(18)
(0)